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Transducer of Cdc42-dependent actin 
assembly protein 1 (TOCA1) is an effector of 
the Rho family small G protein Cdc42. It 
contains a membrane-deforming F-BAR 
domain as well as an SH3 domain and a G 
protein-binding HR1 (homology region 1) 
domain. TOCA1 binding to Cdc42 leads to 
actin rearrangements, which are thought to be 
involved in processes such as endocytosis, 
filopodia formation and cell migration. We 
have solved the structure of the HR1 domain 
of TOCA1, providing the first structural data 
for this protein. We have found that the 
TOCA1 HR1, like the closely related CIP4 
HR1, has interesting structural features that 
are not observed in other HR1 domains. We 
have also investigated the binding of the 
TOCA HR1 domain to Cdc42, and the 
potential ternary complex between Cdc42 and 
the G protein binding regions of TOCA1 and a 
member of the Wiskott-Aldrich syndrome 
protein family, N-WASP. TOCA1 binds 
Cdc42 with micromolar affinity, in contrast to 
the nanomolar affinity of the N-WASP G 
protein binding region for Cdc42. NMR 
experiments show that the Cdc42 binding 
domain from N-WASP is able to displace 
TOCA1 HR1 from Cdc42, while the N-WASP 
domain but not the TOCA1 HR1 domain 
inhibits actin polymerisation. This suggests 
that TOCA1 binding to Cdc42 is an early step 
in the Cdc42-dependent pathways that govern 
actin dynamics and the differential binding 
affinities of the effectors facilitate a handover 
from TOCA1 to N-WASP, which can then 





The Ras superfamily of small 
GTPases comprises over 150 members that 
regulate a multitude of cellular processes in 
eukaryotes. The superfamily can be divided 
into five families based on structural and 




functional similarities: Ras, Rho, Rab, Arf and 
Ran. All members share a well-defined core 
structure of ~20 kDa known as the G domain, 
which is responsible for guanine nucleotide 
binding (1). It is this guanine nucleotide 
binding that underlies their function as 
molecular switches, controlling a vast array of 
signalling pathways. These molecular switches 
cycle between active, GTP-bound, and 
inactive, GDP-bound, states with the help of 
auxiliary proteins. The guanine nucleotide 
exchange factors mediate formation of the 
active state by promoting the dissociation of 
GDP, allowing GTP to bind. The GTPase 
activating proteins stimulate the rate of 
intrinsic GTP-hydrolysis, mediating the return 
to the inactive state (reviewed in 2). 
The overall conformation of small G 
proteins in the active and inactive states is 
similar but they differ significantly in two 
main regions known as switch I and switch II. 
These regions are responsible for ‘sensing’ the 
nucleotide-state, with the GTP-bound state 
showing greater rigidity and the GDP-bound 
state adopting a more relaxed conformation 
(reviewed in 3). In the active state, G proteins 
bind to an array of downstream effectors, 
through which they exert their extensive roles 
within the cell. The structures of more than 60 
small G protein-effector complexes have been 
solved and, not surprisingly, the switch 
regions have been implicated in a large 
proportion of the G protein-effector 
interactions (reviewed in 4). However, as each 
of the 150 members of the superfamily 
interacts with multiple effectors, there are still 
a huge number of known G protein-effector 
interactions that have not yet been studied 
structurally. 
 The Rho family comprises 20 
members, of which three, RhoA, Rac1 and 
Cdc42, have been relatively well studied. The 
role of these three proteins in the coordination 
of the actin cytoskeleton has been extensively 
examined (5–10). RhoA acts to rearrange 
existing actin structures to form stress fibres, 
while Rac1 and Cdc42 promote de novo actin 
polymerisation to form lamellipodia and 
filopodia respectively (9–12). A number of 
RhoA and Rac1 effector proteins, including 
the Formins (13) and members of the Protein 
Kinase C-related Kinase (PRK)1 family (14), 
along with Cdc42 effectors including the 
Wiskott-Aldrich Syndrome (WASP) family 
(15) and the transducer of Cdc42-dependent 
actin assembly (TOCA) family (16–18) have 
also been linked to the pathways that govern 
cytoskeletal dynamics.  
Cdc42 effectors, TOCA1 and the 
ubiquitously expressed member of the WASP 
family, N-WASP, have been implicated in the 
regulation of actin polymerisation downstream 
of Cdc42 and phosphatidylinositol 4,5-
bisphosphate [PI(4,5)P2] (9, 16, 19–22). N-
WASP exists in an autoinhibited 
conformation, which is released upon 
PI(4,5)P2 and Cdc42 binding (21, 23) or by 
other factors such as phosphorylation (24). 
Following their release, the C-terminal regions 
of N-WASP are free to interact with G-actin 
and a known nucleator of actin assembly, the 
Arp2/3 complex (25). The importance of 
TOCA1 in actin polymerisation has been 
demonstrated in a range of in vitro and in vivo 
studies (16, 26–32) but the exact role of 
TOCA1 in the many pathways involving actin 
assembly remains unclear. The most widely 
studied role of TOCA1 is in membrane 
invagination and endocytosis (28–30, 33, 34), 
although it has also been implicated in 
filopodia formation (27), neurite elongation 
(35), transcriptional reprogramming via 
nuclear actin (36) and interaction with ZO-1 at 
tight junctions (37). A role in cell motility and 
invasion has also been established (38, 39). 
TOCA1 comprises an N-terminal F-
BAR domain, a central homology region 1 
(HR1) domain and a C-terminal SH3 domain. 
The F-BAR domain is a known dimerisation, 
membrane-binding and membrane-deforming 
module (33, 40, 41) found in a number of cell 
signalling proteins. The TOCA1 SH3 domain 
has many known binding partners, including 
N-WASP (16) and Dynamin (40). The HR1 
domain has been directly implicated in the 
interaction between TOCA1 and Cdc42 (16), 
representing the first Cdc42-HR1 domain 
interaction to be identified.  
Other HR1 domains studied so far, 
including those from the PRK family, have 




been found to bind their cognate Rho family G 
protein-binding partner with high specificity 
and affinities in the nanomolar range (42–45). 
The structures of the PRK1 HR1a domain in 
complex with RhoA (42) and the HR1b 
domain in complex with Rac1 (46) show that 
the HR1 domain comprises an anti-parallel 
coiled-coil that interacts with its G protein 
binding partner via both helices. Both of the G 
protein switch regions are involved in the 
interaction. The coiled-coil fold is shared by 
the HR1 domain of the TOCA family protein, 
CIP4 (47) and, based on sequence homology, 
by TOCA1 itself. These HR1 domains, 
however, show specificity for Cdc42, rather 
than RhoA or Rac1 (16, 17). How different 
HR1 domain proteins distinguish their specific 
G protein partners remains only partially 
understood and structural characterisation of a 
novel G protein-HR1 domain interaction 
would add to the growing body of information 
pertaining to these protein complexes. 
Furthermore, the biological function of the 
interaction between TOCA1 and Cdc42 
remains poorly understood and so far there has 
been no biophysical or structural insight.  
The interactions of TOCA1 and N-
WASP with Cdc42 as well as with each other 
has raised questions as to whether the two 
Cdc42-effectors can interact with a single 
molecule of Cdc42 simultaneously. There is 
some evidence for a ternary complex between 
Cdc42, N-WASP and TOCA1 (30) but there 
was no direct demonstration of simultaneous 
contacts between the two effectors and a 
single molecule of Cdc42. Nonetheless, the 
substantially different structures of the G 
protein binding regions of the two effectors is 
intriguing, and implies that they bind to Cdc42 
quite differently, providing motivation for 
investigating the possibility that Cdc42 can 
bind both effectors concurrently. WASP 
interacts with Cdc42 via a conserved, 
unstructured binding motif known as the 
Cdc42- and Rac-interactive binding region 
(CRIB) (48), which forms an intermolecular 
β-sheet, expanding the anti-parallel β2 ad β3 
strands of Cdc42 (49). In contrast, the TOCA 
family proteins are thought to interact via the 
HR1 domain, which may form a triple coiled-
coil with switch II of Rac1, like the HR1b 
domain of PRK1 (46).  
Here, we present the solution NMR 
structure of the HR1 domain of TOCA1, 
providing the first structural data for this 
protein. We also present data pertaining to 
binding of the TOCA HR1 domain to Cdc42, 
which is the first biophysical description of an 
HR1 domain binding this particular Rho-
family small G protein. Finally, we investigate 
the potential ternary complex between Cdc42 
and the G protein-binding regions of TOCA1 
and N-WASP, contributing to our 
understanding of G protein-effector 
interactions as well as the roles of Cdc42, N-
WASP and TOCA1 in the pathways that 
govern actin dynamics. 
 
EXPERIMENTAL PROCEDURES 
 Expression Constructs - Xenopus 
tropicalis TOCA1 HR1 domain (residues 330-
426 and N-terminally extended constructs as 
indicated) were amplified from cDNA 
(TOCA1 accession number NM_001005148) 
and cloned into pGEX-6P-1 (GE Healthcare) 
or pGEX-HisP (44). The HR1 domain of 
human CIP4 (residues 388-481) was amplified 
from IMAGE:3532036, the Xenopus laevis 
FBP17 HR1 domain (residues 385-486) from 
IMAGE: 5514481 and the Xenopus tropicalis 
N-WASP/WASL GBD (residues 197-255) 
from IMAGE: 5379332 and all were cloned 
into pGEX-6P-1. The resulting constructs 
express the proteins as N-terminal GST-
fusions with a 3C protease-cleavable tag, with 
pGEX-HisP expressing an additional C-
terminal His6-tag. Human Cdc42Δ7Q61L and 
full-length Cdc42 were cloned into pGEX-2T 
(GE Healthcare) and pGEX-6P-1 respectively. 
A C-terminally extended construct of TOCA1 
comprising residues 330-545 was cloned into 
pMAT10-P (D. Owen, unpublished). The 
resulting construct expresses TOCA1 330-545 
as an N-terminal His-MBP fusion protein with 
a 3C protease-cleavable tag. Full-length 
Xenopus tropicalis TOCA1, TOCA1 F-BAR 
(residues 1-287) and TOCA1 ΔSH3 (residues 
1-480) were PCR amplified from a cDNA 
clone (IMAGE: 5157175) and cloned into 
pET-6xHis-SNAP using FseI and AscI sites 




that had been incorporated into the primers to 
create His-SNAP-TOCA1 proteins.  
 Protein Expression – GST fusion 
proteins (HR1 domains and Cdc42) were 
expressed in E. coli BL21 cells (Invitrogen). 
Stationary cultures were diluted 1 in 10 and 
grown at 37 °C until an A600 ~ 0.8 was 
reached, then induced with 0.1 mM isopropyl-
β-D-thiogalactopyranoside for 20 hours at 20 
°C. The GST-N-WASP GBD construct was 
expressed in E. coli BL21-CodonPlus®-RIL 
(Agilent Technologies). The proteins were 
purified using glutathione-agarose beads 
(Sigma) and eluted from the beads by cleavage 
of the GST-tag with 3C protease (HR1 
domains, N-WASP GBD and full-length 
Cdc42Q61L) or Thrombin (Novagen, 
Cdc42Δ7Q61L) prior to gel filtration on a 
16/60 S75 column (GE Healthcare). His-
MBP-HR1-SH3 was purified using nickel-
NTA-agarose beads (Life Technologies) prior 
to cleavage with 3C protease and gel filtration. 
Full-length TOCA1, TOCA1 F-BAR and 
TOCA1 ΔSH3 were expressed from pET-
6xHis-SNAP in BL21 pLysS, grown at 37 °C 
until an A600 of ~ 0.6 was reached and induced 
with 0.3 mM isopropyl-β-D-
thiogalactopyranoside overnight at 19 °C. 
Proteins were coupled to Ni-NTA-agarose 
(Qiagen), eluted using increasing 
concentrations of imidazole and further 
purified by gel filtration using a 16/60 S200 
column (GE Healthcare). All protein 
concentrations were determined by amino acid 
analysis (PNAC Facility, Department of 
Biochemistry, University of Cambridge).  
Nucleotide Exchange - For NMR experiments, 
Cdc42 was nucleotide exchanged for the non-
hydrolysable GTP analogue GMPPNP 
(Sigma) as described previously (50). For 
SPAs, Cdc42 was loaded with [3H]GTP using 
[8-3H]GTP (Perkin Elmer) as described 
previously (51). The protein was confirmed as 
full-length using mass spectrometry (PNAC 
facility, Department of Biochemistry, 
University of Cambridge). 
 Scintillation Proximity Assays (SPAs) 
- Direct: GST-PAK, GST-ACK or His-tagged 
TOCA1 constructs were attached to a 
fluromicrosphere via an anti-GST or anti-His 
antibody in the presence of 
Cdc42Δ7Q61L·[3H]GTP. Binding curves were 
fitted using a direct binding isotherm to obtain 
Kd values and their curve-fitting errors for the 
G protein-effector interactions (52). 
Competition: free ACK GBD, TOCA1 HR1, 
TOCA1 HR1SH3 or N-WASP GBD were 
titrated into a mixture of 30 nM 
Cdc42Δ7Q61L·[3H]GTP and 30 nM GST-
ACK immobilised on a fluromicrosphere as 
above. Data were fitted to competition binding 
isotherms to obtain Kd values and curve-fitting 
errors, as described previously (53). 
 NMR Spectroscopy - The NMR 
experiments and resonance assignments of the 
HR1 domain are described (54). The NMR 
experiments were carried out with 0.9 mM 
13C/15N-labelled HR1 domain in 20 mM 
sodium phosphate pH 7.5, 150 mM NaCl, 5 
mM MgCl2, 5 mM DTT, 10 % D2O.  Distance 
restraints were derived from a 15N-separated 
NOESY (100 msec mixing time) recorded on 
a Bruker DRX500 and a 13C-separated 
NOESY (100 msec mixing time) recorded on 
an Avance AV600. NMR data were processed 
using AZARA (W. Boucher), University of 
Cambridge and analysed using ANALYSIS 
(55).  
 Structure Calculation - Structures 
were calculated iteratively using CNS 1.0 
interfaced to Aria2.3.1 (56). The PROSLQ 
force field was used for non-bonded 
parameters. Backbone torsion angles were 
estimated from CA, CO, CB, N and HA 
chemical shifts using TALOS-N (57) .The 
“strong” φ and ψ restraints were included with 
an error of ± 2 standard deviations of the 
averaged TALOS-N predictions. Dihedral 
angle predictions for residues 323-340 were 
weak and so no restraints were included for 
this region. 
 NMR Titrations - All of the 15N- and 
13C-HSQCs were recorded at 25 ˚C in 50 mM 
sodium phosphate pH 5.5, 25 mM NaCl, 5 
mM MgCl2, 5 mM DTT, 10 % D2O on a 
Bruker DRX500. 15N-HR1 HSQC experiments 
were recorded on 0.2 mM 15N-HR1 domain 
with HR1:Cdc42·GMPPNP ratios of 1:0, 
1:0.25, 1:0.5, 1:1 and 1:4.  Experiments were 
recorded on 0.27 mM 15N-Cdc42·GMPPNP at 




Cdc42:HR1 ratios of 1:0, 1:0.25, 1:0.5 and 
1:2.2. The 15N-HSQC titrations with N-WASP 
were recorded on 0.6 mM 15N-HR1 domain or 
0.15 mM 15N-Cdc42 at the ratios indicated in 
the figures. 
 Chemical Shift Mapping - The 
chemical shift changes, δ, were calculated 
using the equation: 
 
 where d1H and d15N are the chemical shift 
changes for the 1H and 15N dimensions 
respectively. Residues that had disappeared 
were assigned a δ value larger than the 
maximum calculated δ for the data set and 
residues that were too overlapped to be 
reliably assigned in the complex spectra were 
assigned δ = 0. The residues that had shifted 
more than the mean chemical shift change 
across the spectrum were classed as significant 
and were filtered for solvent accessibility 
using NACCESS (58). Residues with less than 
50 % solvent accessibility were considered to 
be buried and unavailable for binding. 
 Pyrene actin assays - Pyrene actin 
assays were carried out as previously 
described in (59). Xenopus high speed 
supernatant was used at 5 mg/mL and 
supplemented with 0.12 mg/mL pyrene actin 
as described previously (32). TOCA1 HR1 
domain or N-WASP CRIB domain was added 
at the concentrations indicated. Liposomes 
were made using previously described 
methods (60), from 60 % phosphatidylcholine, 
30 % phosphatidylserine and 10 % PI(4,5)P2 
to 2 mM final lipid concentration. All of the 
lipids used were natural brain or liver lipids 
from Avanti Polar Lipids. The assays were 
initiated by addition of 5 µL of liposomes per 




TOCA1 was identified in Xenopus 
extracts as a protein necessary for Cdc42-
dependent actin assembly (16) and was shown 
to bind to Cdc42·GTPγS but not to 
Cdc42·GDP or to Rac1 and RhoA. Given its 
homology to other Rho-family binding 
modules, it is likely that the HR1 domain of 
TOCA1 is sufficient to bind Cdc42. The C. 
elegans TOCA1 orthologues also bind to 
Cdc42 via their consensus HR1 domain (34). 
The HR1 domains from the PRK family bind 
their G protein partners with a high affinity, 
exhibiting a range of sub-micromolar 
dissociation constants (Kd) as low as 26 nM 
(45). A Kd in the nM range was therefore 
expected for the interaction of the TOCA1 
HR1 domain with Cdc42. 
We generated a X. tropicalis TOCA1 
HR1 domain construct encompassing residues 
330-426. This region comprises the complete 
HR1 domain based on secondary structure 
predictions and sequence alignments with 
another TOCA family member, CIP4, whose 
structure has been determined (47). The 
interaction between [3H]GTP⋅Cdc42 and a C-
terminally His-tagged TOCA1 HR1 domain 
construct was investigated using scintillation 
proximity assays (SPA). The binding isotherm 
for the interaction is shown in Figure 1A, 
together with the Cdc42-PAK interaction as a 
positive control (52). The binding of TOCA1 
HR1 to Cdc42 was unexpectedly weak, with a 
Kd  > 1 µM. It was not possible to estimate the 
Kd more accurately using direct SPA 
experiments, as saturation could not be 
reached due to non-specific signal at higher 
protein concentrations. 
It was possible that the low affinity 
observed was due to negative effects of 
immobilization of the HR1 domain and so 
other methods were employed, which utilized 
untagged proteins.  Isothermal titration 
calorimetry was carried out but no heat 
changes were observed at a range of 
concentrations and temperatures (data not 
shown), suggesting that the interaction is 
predominantly entropically driven. Other G 
protein-HR1 domain interactions have also 
failed to show heat changes in our hands (DO, 
unpublished data). Infrared interferometry 
with immobilized Cdc42 was also attempted, 
but was unsuccessful for both TOCA1 HR1 
and for the positive control, ACK. 
The affinity was therefore determined 
using competition SPAs. A complex of a 
GST-fusion of the G protein binding domain 









affinity to Cdc42 (61), with radiolabelled 
[3H]GTP⋅Cdc42 was pre-formed and the effect 
of increasing concentrations of untagged 
TOCA1 HR1 domain was examined. 
Competition of GST-ACK bound to 
[3H]GTP⋅Cdc42 by free ACK GBD was used 
as a control and to establish the value of 
background counts when Cdc42 is fully 
displaced. The data were fitted to a binding 
isotherm describing competition (53). Free 
ACK competed with itself with an affinity of 
32 nM, similar to the value obtained by direct 
binding of 23 nM (61). The TOCA1 HR1 
domain also fully competed with the GST-
ACK but bound with an affinity of 6 µM 
(Figure 1B and C), in agreement with the low 
affinity observed in the direct binding 
experiments. 
The Cdc42 construct used in the 
binding assays has 7 residues deleted from the 
C-terminus to facilitate purification. These 
residues are not generally required for G 
protein-effector interactions, including the 
interaction between RhoA and the PRK1 
HR1a domain (53). In contrast, the C-terminus 
of Rac1 contains a polybasic sequence, which 
is crucial for Rac1 binding to the HR1b 
domain from PRK1 (43, 46). As the observed 
affinity between TOCA1 HR1 and Cdc42 was 
much lower than expected, we reasoned that 
the C-terminus of Cdc42 might be necessary 
for a high affinity interaction. The binding 
experiments were repeated with full-length 
[3H]GTP⋅Cdc42 but the affinity of the HR1 
domain for full-length Cdc42 was similar to its 
affinity for truncated Cdc42 (Kd ≈ 5 µM, 
Figure 1C). Thus, the C-terminal region of 
Cdc42 is not required for maximal binding of 
TOCA1 HR1. 
Another possible explanation for the 
low affinities observed was that the HR1 
domain alone is not sufficient for maximal 
binding of the TOCA proteins to Cdc42 and 
that the other domains are required. Indeed, 
GST-pull downs performed with in vitro 
translated human TOCA1 fragments had 
suggested that residues N-terminal to the HR1 
domain may be required to stabilize the HR1 
domain structure (16). Furthermore, both BAR 
and SH3 domains have been implicated in 
interactions with small G proteins e.g. the 
BAR domain of Arfaptin2 binds to Rac1 and 
Arl1 (62) while an SH3 domain mediates the 
interaction between Rac1 and the guanine 
nucleotide exchange factor, β-PIX (63). 
TOCA1 dimerizes via its F-BAR domain, 
which could also affect Cdc42 binding, for 
example by presenting two HR1 domains for 
Cdc42 interactions. Various TOCA1 
fragments (Figure 2A) were therefore assessed 
for binding to full-length Cdc42 by direct 
SPA. The isolated F-BAR domain showed no 
binding to full-length Cdc42 (Figure 2B). Full-
length TOCA1 and ΔSH3 TOCA1 bound with 
micromolar affinity (Figure 2B), in a similar 
manner to the isolated HR1 domain (Figure 
1A). The HR1-SH3 protein could not be 
purified to homogeneity as a fusion protein so 
was assayed in competition assays after 
cleavage of the His tag. This construct 
competed with GST-ACK GBD to give a 
similar affinity to the HR1 domain alone (Kd = 
4.6 ± 4 µM, Figure 2C). Taken together, these 
data suggest that the TOCA1 HR1 domain is 
sufficient for maximal binding and that this 
binding is of a relatively low affinity 
compared to many other Cdc42-effector 
complexes.  
The low affinity of the TOCA1 HR1-
Cdc42 interaction raised the question as to 
whether the other known Cdc42-binding 
TOCA family proteins, FBP17 (18) and CIP4 
(17), also bind weakly. The HR1 domains 
from FBP17 and CIP4 were purified and 
assayed for Cdc42 binding in competition 
SPAs, analogous to those carried out with the 
TOCA1 HR1 domain. The affinity of both the 
FBP17 and CIP4 HR1 domains were also in 
the low micromolar range (10 and 5 µM 
respectively) (Figure 2D and E), suggesting 
that low affinity interactions with Cdc42 are a 
common feature within the TOCA family. 
 
Structure of the TOCA1 HR1 Domain 
As the TOCA1 HR1 domain was 
sufficient for maximal Cdc42-binding, we 
used this construct for structural studies. Initial 
experiments were performed with TOCA1 
residues 324-426 but we observed that the N-
terminus was cleaved during purification to 




yield a new N-terminus at residue 330 (data 
not shown). We therefore engineered a 
construct comprising residues 330-426 to 
produce the minimal, stable HR1 domain. 
Backbone and sidechain resonances were 
assigned as described (54). 2,778 non-
degenerate NOE restraints were used in initial 
structure calculations (1,791 unambiguous and 
987 ambiguous), derived from 3D 15N-
separated NOESY and 13C-separated NOESY 
experiments. There were 1,845 unambiguous 
NOEs and 757 ambiguous NOEs after 8 
iterations. 100 structures were calculated in 
the final iteration, the 50 lowest energy 
structures were water refined and of these the 
35 lowest energy structures were analysed. 
Table 1 indicates that the HR1 domain 
structure is well defined by the NMR data. 
The structure closest to the mean is 
shown in Figure 3A. The two α-helices of the 
HR1 domain interact to form an anti-parallel 
coiled-coil with a slight left-handed twist, 
reminiscent of the HR1 domains of CIP4 (47) 
(PDB Code:2KE4) and PRK1 (42, 43) (PDB 
Codes:1CXZ,1URF). A sequence alignment 
illustrating the secondary structure elements of 
the TOCA1 and CIP4 HR1 domains and the 
HR1a and HR1b domains from PRK1 is 
shown in Figure 3B. 
In the HR1a domain of PRK1, a 
region N-terminal to helix 1 forms a short α-
helix, which packs against both helices of the 
HR1 domain (42). This region of TOCA1 
HR1 (residues 334-340) is well defined in the 
family of structures (Figure 3A) but does not 
form an α-helix. It instead forms a series of 
turns, defined by NOE restraints observed 
between residues separated by one (332-334, 
333-335 etc.) or two (337-340) residues in the 
sequence and the φ and ψ angles, assessed 
using Stride (64). These turns cause the chain 
to reverse direction, allowing the N-terminal 
segment (334-340) to contact both helices of 
the HR1 domain. Long range NOEs were 
observed linking Leu334, Glu335 and Asp336 
with Trp413 of helix 2, Leu334 with Lys409 
of helix 2, and Phe337 and Ser338 with 
Arg345, Arg348 and Leu349 of helix 1. These 
contacts are summarized in Figure 3C. 
The two α-helices of TOCA1 HR1 are 
separated by a long loop of ten residues (380-
389) that contains two short 310 helices 
(residues 381-383 and 386-389). Interestingly, 
sidechains of residues within the loop region 
point back towards helix 1; for example, there 
are numerous distinct NOEs between the 
sidechains of Asn380 and Met383 of the loop 
region and Tyr377 and Val376 of helix 1 
(Figure 3D). The backbone NH and CHα 
groups of Gly384 and Asp385 also show 
NOEs with the sidechain of Tyr377.  
 
Mapping the TOCA1 and Cdc42 Binding 
Interfaces 
The HR1TOCA1-Cdc42 interface was 
investigated using NMR spectroscopy. A 
series of 15N-HSQC experiments was recorded 
on 15N-labelled TOCA1 HR1 domain in the 
presence of increasing concentrations of 
unlabelled Cdc42Δ7Q61L·GMPPNP to map 
the Cdc42-binding surface. A comparison of 
the 15N-HSQC spectra of free HR1 and HR1 in 
the presence of excess Cdc42 shows that 
although some peaks were shifted, several 
were much broader in the complex and a 
considerable subset had disappeared (Figure 
4A). This behaviour cannot be explained by 
the increase in molecular mass (from 12 kDa 
to 33 kDa) when Cdc42 binds and is more 
likely to be due to conformational exchange. 
This leads to broadening of the peaks so that 
they are not detectable. Overall chemical shift 
perturbations (CSP) were calculated for each 
residue, while those that had disappeared were 
assigned a shift change of 0.2 (Figure 4B). A 
peak that disappeared or had a CSP above the 
mean CSP for the spectrum was considered to 
be significantly affected.  
15N-HSQC shift mapping experiments 
report on changes to amide groups, which are 
mainly inaccessible as they are buried inside 
the helices and are involved in hydrogen 
bonds. Therefore, 13C-HSQC and methyl-
selective SOFAST-HMQC (65) experiments 
were also recorded on 15N,13C-labelled 
TOCA1 HR1 to yield more information on 
sidechain involvement. The affected CH 
groups underwent significant line broadening, 
similarly to the NH peaks. Sidechains whose 




CH groups disappeared in the presence of 
Cdc42 are marked on the graph in Figure 4B 
with green asterisks. 
TOCA1 residues whose signals were 
affected by Cdc42 binding were mapped onto 
the structure of TOCA1 HR1 (Figure 4C). The 
changes were localized to one end of the 
coiled-coil and the binding site appeared to 
include residues from both α-helices and the 
loop region that joins them. Residues outside 
this region were not significantly affected, 
indicating that there was no widespread 
conformational change. The residues in the 
interhelical loop and helix 1 that contact each 
other (Figure 3D) show shift changes in their 
backbone NH and sidechains in the presence 
of Cdc42. For example, the sidechain of 
Asn380, and the backbones of Val376 and 
Tyr377 were significantly affected but are all 
buried in the free TOCA1 HR1 structure, 
indicating that local conformational changes in 
the loop may facilitate complex formation. 
The chemical shift mapping data indicate that 
the G protein binding region of the TOCA1 
HR1 domain is broadly similar to that of the 
CIP4 and PRK1 HR1 domains (Figure 4D; 
Figure 3B). 
The corresponding 15N- and 13C-NMR 
experiments were also recorded on 15N-
Cdc42Δ7Q61L·GMPPNP or 15N/13C -
Cdc42Δ7Q61L·GMPPNP  in the presence of 
unlabelled HR1 domain. The overall CSP was 
calculated for each residue. As was the case 
when labelled HR1 was observed, several 
peaks were shifted in the complex but many 
disappeared, indicating exchange on an 
unfavourable, millisecond timescale (Figure 
5A). Detailed sidechain data could not be 
obtained for all residues due to spectral 
overlap but constant-time 13C-HSQC and 
methyl-selective SOFAST-HMQC 
experiments provided further information on 
certain, well-resolved sidechains (marked with 
green asterisks in Figure 5B).  
As many of the peaks disappeared, the 
mean chemical shift change was relatively low 
and so a threshold of the mean plus one 
standard deviation was used to define a 
significant CSP. Residues that disappeared 
were also classed as significantly affected. 
Parts of the switch regions (Figure 5B, C) are 
invisible in NMR spectra recorded on free 
Cdc42 due to conformational exchange. These 
switch regions become visible in Cdc42 and 
other small G protein-effector complexes (46, 
61, 66) due to a decrease in conformational 
freedom upon complex formation. The switch 
regions of Cdc42 did not, however, become 
visible in the presence of the TOCA1 HR1 
domain. Indeed, Ser30 of switch I and Arg66, 
Arg68, Leu70 and Ser71 of switch II are 
visible in free Cdc42 but disappear in the 
presence of the HR1 domain. This suggests 
that the switch regions are not rigidified in the 
HR1 complex and are still in conformational 
exchange. Nevertheless, mapping of the 
affected residues onto the NMR structure of 
free Cdc42Δ7Q61L·GMPPNP (Figure 5C, 
HRM and DO, unpublished) shows that 
although they are relatively widespread 
compared to changes in the HR1 domain in 
general they are on the face of the protein that 
includes the switches. Although the binding 
interface may be overestimated, this suggests 
that the switch regions are involved in binding 
to TOCA1.   
 
Modelling the Cdc42-TOCA1 HR1 Complex 
The Cdc42-HR1TOCA1 complex was 
not amenable to full structural analysis due to 
the weak interaction and the extensive 
exchange broadening seen in the NMR 
experiments. HADDOCK (67) was, therefore, 
used to perform rigid body docking based on 
the structures of free HR1 domain and Cdc42 
and ambiguous interaction restraints derived 
from the titration experiments described 
above. Residues with significantly affected 
resonances and more than 50 % solvent 
accessibility were defined as active. Passive 
residues were defined automatically as those 
neighbouring active residues. 
The orientation of the HR1 domain 
with respect to Cdc42 cannot be definitively 
concluded in the absence of unambiguous 
distance restraints and hence HADDOCK 
produced a set of models in which the HR1 
domain contacts the same surface on Cdc42 
but is in various orientations with respect to 
Cdc42. The cluster with the lowest RMSD 




from the lowest energy structure is assumed to 
be the best model. By these criteria, in the best 
model the HR1 domain is in a similar 
orientation to the HR1a domain of PRK1 
bound to RhoA and the HR1b domain bound 
to Rac1. A representative model from this 
cluster is shown in Figure 6A alongside the 
Rac1-HR1b structure (46) (PDB Code:2RMK) 
in Figure 6B. 
A sequence alignment of RhoA, 
Cdc42 and Rac1 is shown in Figure 6C. The 
RhoA and Rac1 contact residues in the switch 
regions are invisible in the spectra of Cdc42 
but they are generally conserved between all 
three G proteins. Several Cdc42 residues 
identified by chemical shift mapping are not in 
close contact in the Cdc42-TOCA1 model 
(Figure 6A). Some of these can be 
rationalized, for example, Thr24Cdc42, 
Leu160Cdc42 and Lys163Cdc42 all pack behind 
switch I and are likely to be affected by 
conformational changes within the switch, 
while Glu95Cdc42, Lys96Cdc42 are in the helix 
behind switch II. Other residues that are 
affected in the Cdc42-TOCA1 complex but 
that do not correspond to contact residues of 
RhoA or Rac1 (Figure 6C) include Gln2Cdc42, 
Lys16Cdc42, Thr52Cdc42 and Arg68Cdc42. 
Lys16Cdc42 is unlikely to be a contact residue 
as it is involved in nucleotide binding but the 
others may represent specific Cdc42-TOCA1 
contacts. In the model these sidechains are 
involved in direct contacts (Figure 6D). 
 
Competition between N-WASP and TOCA1 
From the known interactions and 
effects of the proteins in biological systems, it 
has been suggested that TOCA1 and N-WASP 
could bind Cdc42 simultaneously (16).  
Studies in CHO cells indicated that a Cdc42-
N-WASP-TOCA1 complex existed (30), since 
FRET was observed between RFP-TOCA1 
and GFP-N-WASP and the efficiency was 
decreased when an N-WASP mutant was used 
that no longer binds Cdc42. An overlay of the 
HADDOCK model of the Cdc42-HR1TOCA1 
complex and the structure of Cdc42 in 
complex with the GBD of the N-WASP 
homologue, WASP (49) (PDB Code: 1CEE), 
shows that the HR1 and GBD binding sites 
only partly overlap and, therefore, a ternary 
complex remained possible (Figure 7A). 
Interestingly, the presence of the TOCA1 HR1 
would not prevent the core CRIB of WASP 
from binding to Cdc42, although the regions 
C-terminal to the CRIB that are required for 
high affinity binding of WASP (68) would 
interfere sterically with the TOCA1 HR1. A 
basic region in WASP including three lysines 
(230-232), N-terminal to the core CRIB, has 
been implicated in an electrostatic steering 
mechanism (69) and these residues would be 
free to bind in the presence of TOCA1 HR1 
(Figure 7A). 
An N-WASP GBD construct was 
produced and its affinity for Cdc42 measured 
by competition SPA (Figure 7B). The Kd that 
was determined (37 nM) is consistent with the 
previously reported affinity (69). Unlabelled 
N-WASP GBD was titrated into 15N-
Cdc42Δ7Q61L·GMPPNP and the backbone 
NH groups monitored using HSQCs (Figure 
7C). Unlabelled HR1TOCA1 was then added to 
the Cdc42-N-WASP complex and no changes 
were seen, suggesting that the N-WASP GBD 
was not displaced even in the presence of a 5-
fold excess of HR1TOCA1. These experiments 
were recorded at suffciently high protein 
concentrations (145 µM Cdc42, 145 µM N-
WASP GBD, 725 µM TOCA1 HR1 domain) 
to be far in excess of the Kds of the individual 
interactions (TOCA1 Kd ≈ 5 µM, N-WASP Kd 
= 37 nM). A comparison of the HSQC 
experiments recorded on 15N-Cdc42 alone, in 
the presence of TOCA1 HR1, N-WASP GBD, 
or both, shows that the spectra in the presence 
of N-WASP and in the presence of both N-
WASP and TOCA1 HR1 are identical (Figure 
7C). 
Furthermore, 15N-TOCA1 HR1 was 
monitored in the presence of unlabelled 
Cdc42Δ7Q61L·GMPPNP (1:1) before and 
after addition of 0.25 and 1.0 equivalents of 
unlabelled N-WASP GBD. The spectrum 
when N-WASP and TOCA1 were equimolar 
was identical to that of the free HR1 domain, 
while the spectrum in the presence of 0.25 
equivalents of N-WASP was intermediate 
between the TOCA1 HR1 free and complex 
spectra  (Figure 7D). When in fast exchange, 




the NMR signal represents a population-
weighted average between free and bound 
states and so the intermediate spectrum 
indicates that the population comprises a 
mixture of free and bound HR1 domain. 
Hence a third, intermediate state that includes 
all three proteins is unlikely. Again, the 
experiments were recorded on protein samples 
far in excess of the individual Kds (600 µM of 
each protein). These data indicate that the 
HR1 domain is displaced from Cdc42 by N-
WASP and that a ternary complex comprising 
TOCA1 HR1, N-WASP GBD and Cdc42 is 
not formed. Taken together, the data in Figure 
7C and D indicate unidirectional competition 
for Cdc42 binding in which the N-WASP 
GBD displaces TOCA1 HR1 but not vice 
versa. 
To extend these studies to a more 
complex system and to assess the ability of 
TOCA1 HR1 to compete with full length N-
WASP, pyrene actin assays were employed. 
These assays, described in detail elsewhere, 
(59) were carried out using pyrene actin-
supplemented Xenopus extracts into which 
exogenous TOCA1 HR1 domain or N-WASP 
GBD was added, to assess their effects on 
actin polymerisation. Actin polymerisation in 
all cases was initiated by the addition of 
PI(4,5)P2-containing liposomes. Actin 
polymerisation triggered by addition of 
PI(4,5)P2-containing liposomes has previously 
been shown to depend on TOCA1 and N-
WASP (32). Endogenous N-WASP is present 
at approximately 100 nM in Xenopus extracts, 
while TOCA1 is present at 10-fold lower 
concentration than N-WASP (16). 
Addition of the isolated N-WASP 
GBD significantly inhibited the 
polymerisation of actin at concentrations as 
low as 100 nM and completely abolished 
polymerisation at higher concentrations 
(Figure 8). The GBD presumably acts as a 
dominant negative, sequestering endogenous 
Cdc42 and preventing endogenous full-length 
N-WASP from binding and becoming 
activated. The addition of the TOCA1 HR1 
domain to 100 µM had no significant effect on 
the rate of actin polymerisation or maximum 
fluorescence. This is consistent with 
endogenous N-WASP, activated by other 
components of the assay, outcompeting the 
TOCA1 HR1 domain for Cdc42-binding. 
 
DISCUSSION 
The Cdc42-TOCA1 interaction 
The TOCA1 HR1 domain alone is 
sufficient for Cdc42-binding in vitro and yet 
the affinity of the TOCA1 HR1 domain for 
Cdc42 is remarkably low (Kd ≈ 5 µM). This is 
over 100x lower than that of the N-WASP 
GBD (Kd = 37 nM) and considerably lower 
than other known G protein-HR1 domain 
interactions. The polybasic tract within the C-
terminal region of Cdc42 does not appear to 
be required for binding to TOCA1, which is in 
contrast to the interaction between Rac1 and 
the HR1b domain of PRK1 but more similar to 
the PRK1 HR1a-RhoA interaction. A single 
binding interface on both the HR1 domain and 
Cdc42 can be concluded from the data 
presented here. Furthermore, the interfaces are 
comparable to those of other G protein-HR1 
interactions (Figure 4) and the lowest energy 
model produced in rigid body docking 
resembles previously studied G protein-HR1 
complexes (Figure 6). It seems, therefore, that 
the interaction, despite its relatively low 
affinity, is specific and sterically similar to 
other HR1 domain-G protein interactions.  
The TOCA1 HR1 domain is a left-
handed coiled-coil comparable to other known 
HR1 domains (42, 43, 47). A short region N-
terminal to the coiled-coil exhibits a series of 
turns and contacts residues of both helices of 
the coiled-coil (Figure 3). The corresponding 
sequence in CIP4 also includes a series of 
turns but is flexible, while in the HR1a domain 
of PRK1 the equivalent region adopts an α-
helical structure that packs against the coiled-
coil. The contacts between the N-terminal 
region and the coiled-coil are predominantly 
hydrophobic in both cases, but sequence 
specific contacts do not appear to be 
conserved. This region is distant from the G 
protein-binding interface of the HR1 domains, 
so the structural differences may relate to the 
structure and regulation of these domains, 
rather than their G protein interactions.  




The inter-helical loops of TOCA1 and 
CIP4 differ from the same region in the HR1 
domains of PRK1 in that they are longer and 
contain two short stretches of 310-helix. This 
region lies within the G protein-binding 
surface of all of the HR1 domains (Figure 4D). 
TOCA1 and CIP4 both bind weakly to Cdc42, 
whereas the HR1a domain of PRK1 binds 
tightly to RhoA and Rac1 and the HR1b 
domain to Rac1. The structural features shared 
by TOCA1 and CIP4 may therefore be related 
to Cdc42-binding specificity and the low 
affinities. In free TOCA1, the sidechains of 
the inter-helical region make extensive 
contacts with residues in helix 1. Many of 
these residues are significantly affected in the 
presence of Cdc42 and so it is likely that the 
conformation of this loop is altered in the 
Cdc42 complex. These observations therefore 
provide a molecular mechanism whereby 
mutation of Met383Gly384Asp385 to 
Ile383Ser384Thr385 abolishes TOCA1 binding to 
Cdc42 (16). 
The lowest energy model produced by 
HADDOCK using ambiguous interaction 
restraints from the titration data resembled the 
NMR structures of RhoA and Rac1 in 
complex with their HR1 domain partners (42, 
46). Some speculative conclusions can be 
made based on this model. For example, 
Phe56Cdc42, which is not visible in free Cdc42 
or Cdc42-HR1TOCA1, is close to the TOCA1 
HR1 (Figure 6A). Phe56Cdc42, which is a Trp 
in both Rac1 and RhoA (Figure 6C), is 
thought to pack behind switch I when Cdc42 
interacts with ACK, maintaining the switch in 
a binding-competent orientation (70). This 
residue has also been identified as important 
for Cdc42-WASP binding (71). Phe56Cdc42 is 
therefore likely to be involved in the Cdc42-
TOCA1 interaction, probably by stabilising 
the position of switch I.  
Some residues that are affected in the 
Cdc42-HR1TOCA1 complex, but do not 
correspond to contact residues of RhoA or 
Rac1 (Figure 6C), may contact HR1TOCA1 
directly (Figure 6D). Gln2Cdc42, which has also 
been identified as a contact residue in the 
Cdc42-ACK complex (61), contacts 
Val376TOCA1 and Asn380TOCA1 in the model 
and disrupts the contacts between the 
interhelical loop and the first helix of the 
TOCA1 coiled-coil. Thr52Cdc42, which has also 
been identified as making minor contacts with 
ACK (61, 72), falls near the sidechains of 
HR1TOCA1 helix 1, particularly Lys372TOCA1, 
while the equivalent position in Rac1 is 
Asn52Rac1. N52T is one of a combination of 
seven residues found to confer ACK-binding 
on Rac1 (72) and so may represent a specific 
Cdc42-effector contact residue. The position 
equivalent to Lys372TOCA1 in PRK1 is 
Glu58HR1a or Gln151HR1b. Thr52Cdc42-
Lys372TOCA1 may therefore represent a specific 
Cdc42-HR1TOCA1 contact. Arg68Cdc42 of switch 
II is positioned close to Glu395TOCA1 (Figure 
6D), suggesting a direct electrostatic contact 
between switch II of Cdc42 and helix 2 of the 
HR1 domain. The equivalent Arg in Rac1 and 
RhoA is pointing away from the HR1 domains 
of PRK1. The importance of this residue in the 
Cdc42-TOCA1 interaction remains unclear, 
although its mutation reduces binding to 
RhoGAP, suggesting that it can be involved in 
Cdc42 interactions (53). 
The solution structure of the TOCA1 
HR1 domain presented here, along with the 
model of the HR1TOCA1-Cdc42 complex is 
consistent with a conserved mode of binding 
across the known HR1 domain-Rho family 
interactions, despite their differing affinities. 
The weak binding prevented detailed 
structural and thermodynamic studies of the 
complex. Nonetheless, structural studies of the 
TOCA1 HR1 domain, combined with 
chemical shift mapping, have highlighted 
some potentially interesting differences 
between Cdc42-HR1TOCA1 and RhoA/Rac1-
HR1PRK1 binding.  
 We have previously postulated that 
the inherent flexibility of HR1 domains 
contributes to their ability to bind to different 
Rho family G proteins, with Rho binding HR1 
domains displaying increased flexibility, 
reflected in their lower melting temperatures 
(Tm) and Rac binders being more rigid (44, 
45). The Tm of the TOCA1 HR1 domain is 
61.9 °C (data not shown), which is the highest 
Tm that we have measured for an HR1 domain 
thus far. As such the ability of the TOCA1 




HR1 domain to bind to Cdc42 (a close relative 
of Rac1 rather than RhoA) fits this trend. An 
investigation into the local motions, 
particularly in the G protein binding regions, 
may offer further insight into the differential 
specificities and affinities of G protein-HR1 
domain interactions. 
 
Significance of a weak, transient interaction 
The low affinity of the Cdc42-
HR1TOCA1 interaction is consistent with a 
tightly spatially and temporally regulated 
pathway, requiring combinatorial signals 
leading to a series of coincident weak 
interactions that elicit full activation. The HR1 
domains from other TOCA family members, 
CIP4 and FBP17, also bind at low micromolar 
affinities to Cdc42 and so the low affinity 
interaction appears to be commonplace among 
this family of HR1 domain proteins, in 
contrast to the PRK family. Weak, transient 
protein-protein interactions are functionally 
significant in several systems (73–75), for 
example, the binding of adaptor proteins to 
protein cargo during the formation of clathrin-
coated vesicles in endocytosis involves 
multiple interactions of micromolar affinity 
(76, 77).   
The low affinity of the HR1TOCA1-
Cdc42 interaction in the context of the 
physiological concentration of TOCA1 in 
Xenopus extracts (approximately 10 nM) (16) 
suggests that binding between TOCA1 and 
Cdc42 is likely to occur in vivo only when 
TOCA1 is at high local concentrations and 
membrane localized, and therefore in close 
proximity to activated Cdc42. Evidence 
suggests that the TOCA family of proteins are 
recruited to the membrane via an interaction 
between their F-BAR domain and specific 
signalling lipids. For example, electrostatic 
interactions between the F-BAR domain and 
the membrane are required for TOCA1 
recruitment to membrane vesicles and tubules 
(27) and TOCA1-dependent actin 
polymerisation is known to depend 
specifically on PI(4,5)P2 (32). Furthermore, 
the isolated F-BAR domain of FBP17 has 
been shown to induce membrane tubulation of 
brain liposomes and BAR domain proteins 
that promote tubulation cluster on membranes 
at high densities (33). Once at the membrane, 
high local concentrations of TOCA1 could 
exceed the Kd of F-BAR dimerisation (likely 
to be comparable to that of the FCHo2 F-BAR 
domain (2.5 µM) (41)) and that of the Cdc42-
HR1TOCA1 interaction. Cdc42-HR1TOCA1 
binding would then be favourable, as long as 
coincident activation of Cdc42 had occurred, 
leading to stabilization of TOCA1 at the 
membrane and downstream activation of N-
WASP. 
It has been postulated that WASP and 
N-WASP exist in equilibrium between folded 
(inactive) and unfolded (active) forms and the 
affinity of Cdc42 for the unfolded WASP 
proteins is significantly enhanced (78). The 
unfolded, high affinity state of WASP is 
represented by a short peptide, the GBD, 
which binds with a low nM affinity to Cdc42 
(49). In contrast, the best estimate of the 
affinity of full-length WASP for Cdc42 is low 
micromolar (79), In the inactive state of 
WASP, the actin- and Arp2/3-binding VCA 
domain contacts the GBD (21, 23, 80), 
competing for Cdc42 binding. The high 
affinity of Cdc42 for the unfolded, active form 
pushes the equilibrium in favour of (N-
)WASP activation. Binding of PI(4,5)P2 to the 
basic region just N-terminal to the GBD 
further favours the active conformation (21). 
A substantial body of data has illuminated the 
complex regulation of WASP/N-WASP 
proteins and current evidence suggests that 
these allosteric activation mechanisms and 
oligomerization combine to regulate WASP 
activity, allowing the synchronization and 
integration of multiple potential activation 
signals (reviewed in 24). Our data are easily 
reconciled with this model. 
We envisage that TOCA1 is first 
recruited to the appropriate membrane in 
response to PI(4,5)P2 via its F-BAR domain, 
where the local increase in concentration 
favours F-BAR mediated dimerization of 
TOCA1. Cdc42 is activated in response to co-
incident signals and can then bind to TOCA1, 
further stabilising TOCA1 at the membrane. 
TOCA1 can then recruit N-WASP (26) via an 
interaction between its SH3 domain and the N-




WASP proline-rich region (16). The 
recruitment of N-WASP alone and of the N-
WASP/WIP complex by TOCA1 and FBP17 
has been demonstrated (26). WIP inhibits the 
activation of N-WASP by Cdc42, an effect 
that is reversed by TOCA1 (16). It may, 
therefore, be envisaged that WIP and TOCA1 
exert opposing allosteric effects on N-WASP, 
with TOCA1 favouring the unfolded, active 
conformation of N-WASP and increasing its 
affinity for Cdc42. TOCA1 may also activate 
N-WASP by effective oligomerization, as 
clustering of TOCA1 at the membrane 
following coincident interactions with 
PI(4,5)P2 and Cdc42 would in turn lead to 
clustering of N-WASP, in addition to pushing 
the equilibrium towards the unfolded, active 
state. 
In a cellular context full-length 
TOCA1 and N-WASP are likely to have 
similar affinities for active Cdc42 but in the 
unfolded, active conformation, the affinity of 
N-WASP for Cdc42 dramatically increases. 
Our binding data suggests that TOCA1 HR1 
binding is not allosterically regulated and our 
NMR data, along with the high stability of 
TOCA1 HR1, suggest that there is no 
widespread conformational change in the 
presence of Cdc42. As full-length TOCA1 and 
the isolated HR1 domain bind Cdc42 with 
similar affinities, the N-WASP-Cdc42 
interaction will be favoured as the N-WASP 
GBD can easily outcompete the TOCA1 HR1 
for Cdc42. A combination of allosteric 
activation by PI(4,5)P2, activated Cdc42 and 
TOCA1 and oligomeric activation 
implemented by TOCA1 would lead to full 
activation of N-WASP and downstream actin 
polymerisation.  
In such an array of molecules 
localised to a discrete region of the membrane, 
it is plausible that WASP could bind to a 
second Cdc42 molecule, rather than displacing 
TOCA1 from its cognate Cdc42. Our NMR 
and affinity data, however, are consistent with 
displacement of the TOCA1 HR1 by the N-
WASP GBD. Furthermore, TOCA1 is 
required for Cdc42-mediated activation of N-
WASP/WIP (16), implying that it may not be 
possible for Cdc42 to bind and activate N-
WASP prior to TOCA1-Cdc42 binding. The 
commonly used MGDàIST (Cdc42-binding 
deficient) mutant of TOCA1 has a reduced 
ability to activate the N-WASP/WIP complex 
(26), further indicating the importance of the 
Cdc42-HR1TOCA1 interaction prior to 
downstream activation of N-WASP. 
In light of this, we favour an ‘effector 
handover’ scheme whereby TOCA1 interacts 
with Cdc42 prior to N-WASP activation, after 
which N-WASP displaces TOCA1 from its 
bound Cdc42 in order to be fully activated, 
rather than binding a second Cdc42 molecule. 
Potentially the TOCA1-Cdc42 interaction 
functions to position N-WASP and Cdc42 
such that they are poised to interact with high 
affinity. The concomitant release of TOCA1 
from Cdc42 while still bound to N-WASP 
presumably enhances the ability of TOCA1 to 
further activate N-WASP/WIP-induced actin 
polymerisation. There is an advantage to such 
an ‘effector handover’, since N-WASP would 
only be robustly recruited when F-BAR 
domains are already present. Hence, actin 
polymerisation cannot occur until F-BAR 
domains are poised for membrane distortion.  
Our model of the Cdc42-HR1TOCA1 
complex indicates a mechanism by which such 
a handover could take place (Figure 9), as it 
shows that the effector binding sites only 
partially overlap on Cdc42. The lysine 
residues thought to be involved in an 
electrostatic steering mechanism in WASP-
Cdc42 binding (69) are conserved in N-WASP 
and would be able to interact with Cdc42 even 
when the TOCA1 HR1 domain is already 
bound. It has been postulated that the initial 
interactions between this basic region and 
Cdc42 could stabilise the active conformation 
of WASP, leading to high affinity binding 
between the core CRIB and Cdc42 (68). The 
region C-terminal to the core CRIB, required 
for maximal affinity binding (68), would then 
fully displace the TOCA1 HR1. 
In conclusion, the data presented here 
show that the TOCA1 HR1 domain is 
sufficient for Cdc42-binding in vitro and that 
the interaction is of micromolar affinity, lower 
than that of other G protein-HR1 domain 
interactions. The analogous HR1 domains 




from other TOCA1 family members FBP17 
and CIP4 also exhibit micromolar affinity for 
Cdc42. A role for the TOCA1-, FBP17- and 
CIP4-Cdc42 interactions in the recruitment of 
these proteins to the membrane therefore 
appears unlikely. Instead, our findings agree 
with earlier suggestions that the F-BAR 
domain is responsible for membrane-
recruitment (27, 33). The role of the Cdc42-
TOCA1 interaction remains somewhat elusive 
but may serve to position activated Cdc42 and 
N-WASP to allow full activation of N-WASP, 
and as such serve to couple F-BAR mediated 
membrane deformation with N-WASP 
activation. We envisage a complex interplay 
of equilibria between free and bound, active 
and inactive Cdc42, TOCA family and WASP 
family proteins, facilitating a tightly spatially 
and temporally regulated pathway requiring 
numerous simultaneous events in order to 
achieve appropriate and robust activation of 
the downstream pathway. Our data is, 
therefore, easily reconciled with the dynamic 
instability models described in relation to the 
formation of endocytotic vesicles (75) and 
with the current data pertaining to the complex 
activation of WASP/N-WASP pathways by 
allosteric and oligomeric effects (24). 
It is clear from the data presented here 
that TOCA1 and N-WASP do not bind Cdc42 
simultaneously and that N-WASP is likely to 
outcompete TOCA1 for Cdc42-binding. We, 
therefore, postulate an effector handover 
mechanism based on current evidence 
surrounding WASP/N-WASP activation and 
our model of the Cdc42-HR1TOCA1 complex. 
The displacement of the TOCA1 HR1 domain 
from Cdc42 by N-WASP may represent a 
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1 The abbreviations used are: 
PRK – protein kinase C related kinase; WASP – Wiskott-Aldrich syndrome protein; TOCA – 
transducer of Cdc42-dependent actin assembly protein; N-WASP – Neural Wiskott-Aldrich 
syndrome protein; PI(4,5)P2 - phosphatidylinositol 4,5-bisphosphate; HR1 – homology region 1; 
F-BAR – Fes/CIP4 homology BAR; SH3 – Src-homology 3; CRIB – Cdc42- and Rac- interactive 
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p21-activated kinase; ACK – activated Cdc42-associated kinase; NOESY – nuclear Overhauser 
effect spectroscopy; HSQC – heteronuclear single quantum correlation; NOE – nuclear 
Overhauser effect. 
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FIGURE 1. The TOCA1 HR1-Cdc42 interaction is low affinity. A, The curves derived from 
direct binding assays in which the indicated concentrations of Cdc42Δ7Q61L·[3H]GTP were 
incubated with 30 nM GST-PAK or HR1-His6 in SPAs. The SPA signal was corrected by 
subtraction of control data with no GST-PAK or HR1-His6. The data were fitted to a binding 
isotherm to give an apparent Kd and are expressed as a percentage of the maximum signal; B, C, 
Competition SPA experiments were carried out with the indicated concentrations of (B) ACK 
GBD or (C) HR1 domain titrated into 30 nM GST-ACK and either 30 nM 
Cdc42Δ7Q61L·[3H]GTP or full-length Cdc42Q61L·[3H]GTP. The Kd values derived for the ACK 
GBD with Cdc42Δ7 and FL were 0.032 ± 0.01 and 0.011 ± 0.01 µM respectively. The Kd values 
derived for the TOCA1 HR1 with Cdc42Δ7 and FL were 6.05 ± 1.96 and 5.39 ± 1.69 µM 
respectively. 
 
FIGURE 2. The Cdc42-HR1 interaction is of low affinity in the context of full length protein and 
in TOCA1 paralogues. A, A diagram illustrating the TOCA1 constructs assayed for Cdc42 
binding. Domain boundaries are derived from secondary structure predictions; B, The binding 




curves derived from direct binding assays, in which the indicated concentrations of 
Cdc42Δ7Q61L·[3H]GTP were incubated with 30 nM GST-ACK or His-tagged TOCA1 
constructs as indicated, in SPAs. The SPA signal was corrected by subtraction of control data 
with no fusion protein. The data were fitted to a binding isotherm to give an apparent Kd and are 
expressed as a percentage of the maximum signal; C,D,E, Representative examples of 
competition SPA experiments carried out with indicated concentrations of (C) the TOCA1 HR1-
SH3 construct titrated into 30 nM GST-ACK and 30 nM Cdc42Δ7Q61L·[3H]GTP, (D) HR1CIP4 or 
(E) HR1FBP17 titrated into 30 nM GST-ACK and 30 nM Cdc42FLQ61L·[3H]GTP. 
 
FIGURE 3. The structure of the TOCA1 HR1 domain. A, The backbone trace of the 35 lowest 
energy structures of the HR1 domain overlaid with the structure closest to the mean is shown 
alongside a cartoon representation of the structure closest to the mean. Flexible regions at the N- 
and C-termini (330-333 and 421-426) are omitted for clarity; B, A sequence alignment of the 
HR1 domains from TOCA1, CIP4 and PRK1. The secondary structure was deduced using Stride 
(64), based on the Ramachandran angles, and is indicated as follows; grey = turn, yellow = α-
helix, blue = 310 helix, white = coil; C, A close-up of the N-terminal region of TOCA1 HR1, 
indicating some of the NOEs defining its position with respect to the two α-helices. Dotted lines 
indicate NOE restraints; D, A close-up of the interhelix loop region showing some of the contacts 
between the loop and helix 1. NOEs are indicated with dotted lines. All structural figures were 
generated using PYMOL (http://pymol.sourceforge.net).  
 
FIGURE 4. Mapping the binding surface of Cdc42 onto the TOCA1 HR1 domain. A, The 15N-
HSQC of 200 µM TOCA1 HR1 domain is shown in the free form (black) and in the presence of a 
4-fold molar excess of Cdc42Δ7Q61L·GMPPNP (red). Expansions of two regions are shown 
with peak assignments, showing backbone amides in fast or intermediate exchange; B, Chemical 
shift perturbations (CSP) were calculated as described in Materials and Methods and are shown 
for backbone and sidechain NH groups. The mean CSP is marked with a red line. Residues that 
disappeared in the presence of Cdc42 were assigned a CSP of 0.2 but excluded when calculating 
the mean CSP and are indicated with open bars. Those that were not traceable due to spectral 
overlap were assigned a CSP of zero and are marked with an asterisk below the bar. Residues 
with affected sidechain CSPs derived from 13C HSQCs are marked with green asterisks above the 
bars. Secondary structure elements are shown below the graph; C, A cartoon representation of the 
HR1 domain. Residues with significantly affected backbone or sidechain chemical shifts when 
Cdc42 bound and that are buried are coloured dark blue, while those that are solvent accessible 
are coloured yellow. Residues with significantly affected backbone and sidechain groups that are 
solvent accessible are coloured red. A close up of the binding region is shown, with affected 
sidechain heavy atoms shown as sticks; D, The G protein-binding region is marked in red onto 
structures of the HR1 domains as indicated. 
 
FIGURE 5. Mapping the binding surface of the HR1 domain onto Cdc42. A, The 15N-HSQC of 
Cdc42Δ7Q61L·GMPPNP is shown in its free form (black) and in the presence of excess TOCA1 
HR1 domain (1:2.2, red). Expansions of two regions are shown, with most peaks in fast or 
intermediate exchange; B, Chemical shift perturbations (CSP) are shown for backbone NH 
groups. The red line indicates the mean CSP, plus one standard deviation. Residues that 
disappeared in the presence of Cdc42 were assigned a CSP of 0.1 and are indicated with open 
bars. Those that were not traceable due to overlap are marked with an asterisk. Residues with 
disappeared peaks in 13C HSQC experiments are marked on the chart with green asterisks. 
Secondary structure elements are indicated below the graph; C, The residues with significantly 
affected backbone and sidechain groups are highlighted on an NMR structure of free 
Cdc42Δ7Q61L·GMPPNP: those that are buried are coloured dark blue, while those that are 




solvent accessible are coloured red. Residues with either sidechain or backbone groups affected 
are coloured blue if buried and yellow if solvent accessible. Residues without information from 
shift mapping are coloured grey. The flexible switch regions are circled.  
 
FIGURE 6. Model of Cdc42-HR1 complex. A, A representative model of the Cdc42-HR1 
complex from the cluster closest to the lowest energy model produced using HADDOCK (67). 
Residues of Cdc42 that are affected in the presence of the HR1 domain but are not in close 
proximity to it are coloured in red and labelled, B, The structure of Rac1 in complex with the 
HR1b domain of PRK1 (46) (PDB Code: 2RMK), C, A sequence alignment of RhoA, Cdc42 and 
Rac1. Contact residues of RhoA and Rac1 to PRK1 HR1a and HR1b respectively are coloured 
cyan. Residues of Cdc42 that disappear or show chemical shift changes in the presence of 
TOCA1 are coloured cyan if also identified as contacts in RhoA and Rac1 and yellow if they are 
not. Residues equivalent to Rac1 and RhoA contact sites but are invisible in free Cdc42 are grey; 
D, Regions of interest of the Cdc42-HR1 domain model. The four lowest energy structures in the 
chosen HADDOCK cluster are shown overlaid, with the residues of interest shown as sticks and 
labelled. Cdc42 is shown in cyan and TOCA1 in purple. 
 
FIGURE 7. The N-WASP GBD displaces the TOCA1 HR1 domain. A, The model of the Cdc42-
TOCA1 HR1 domain complex overlaid with the Cdc42-WASP structure. Cdc42 is shown in 
green and TOCA1 in purple. The core CRIB region of WASP is shown in red, whilst its basic 
region is in orange and the C-terminal region required for maximal affinity in cyan. A semi-
transparent surface representation of Cdc42 and WASP is shown overlaid with the cartoon; B, 
Competition SPA experiments carried out with indicated concentrations of the N-WASP GBD 
construct titrated into 30 nM GST-ACK or GST-WASP GBD and 30 nM 
Cdc42Δ7Q61L·[3H]GTP; C, Selected regions of the 15N-HSQC of 145 µM 
Cdc42Δ7Q61LGMPPNP with indicated ratios of the TOCA1 HR1 domain, the N-WASP GBD 
or both, showing that the TOCA HR1 domain does not displace the N-WASP GBD; D, Selected 
regions of the 15N-HSQC of 600 µM of the TOCA1 HR1 domain in complex with Cdc42 in the 
absence and presence of the N-WASP GBD, showing displacement of Cdc42 from the HR1 
domain by N-WASP.  
 
FIGURE 8. Actin polymerisation downstream of Cdc42-N-WASP-TOCA1 is inhibited by excess 
N-WASP GBD but not by the TOCA1 HR1 domain. Fluorescence curves showing actin 
polymerisation in the presence of increasing concentrations of N-WASP GDB or TOCA1 HR1 
domain as indicated. Maximal rates of actin polymerisation derived from the linear region of the 
curves are represented in bar charts below. Error bars show standard error of the mean. 
 
FIGURE 9. A simplified model of the early stages of Cdc42/N-WASP/TOCA1-dependent actin 
polymerisation. Step1: TOCA1 is recruited to the membrane via its F-BAR domain and/or Cdc42 
interactions. F-BAR oligomerization is expected to occur following membrane binding but a 
single monomer is shown for clarity. Step 2: N-WASP exists in an inactive, folded conformation. 
The TOCA1 SH3 domain interacts with N-WASP, causing an activator allosteric effect. The 
HR1TOCA1-Cdc42 and SH3TOCA1-N-WASP interactions position Cdc42 and N-WASP for binding. 
Step3: Electrostatic interactions between Cdc42 and the basic region upstream of the CRIB 
initiate Cdc42-N-WASP binding. Step4: The core CRIB binds with high affinity while the region 
C-terminal to the CRIB displaces the TOCA1 HR1 domain and increases the affinity of the N-
WASP-Cdc42 interaction further. The VCA domain is released for downstream interactions and 
actin polymerisation proceeds. WH1 = WASP homology 1 domain, CRIB = Cdc42- and Rac1- 
Interactive binding region, PP = Proline-rich region, VCA = Verprolin homology, cofilin 
homology, acidic region.  











Distance restraints:  
  Total non-degenerate  2602 
Unambiguous  1845  
    Ambiguous  757  
Dihedral angle restraints  164  
  
       <SA> a   <SA> b  
 
Coordinate precision for well-ordered regions 
RMSD of backbone atoms (342-379, 386-419) (Å) 0.67 ± 0.14  0.46 
RMSD of all heavy atoms (342-379, 386-419) (Å) 1.10 ± 0.12   0.96 
 
Ramachandran analysis for all residues 
Residues in most favoured regions:   99.4 %   96.1 % 
Residues in additionally allowed regions:  0.6 %   3.9 % 
Residues in disallowed regions:     0 %   0 % 
 
RMS deviations for all residues 
from the experimental restraints: 
 NOE distances   (Å)    0.011 ± 0.0027   0.011 
 Dihedral angles   (˚)    0.14 ± 0.067  0.18 
      
from idealised geometry: 
 Bonds   (Å)     0.0027 ± 0.00009  0.00269 
 Angles   (˚)     0.434 ± 0.012  0.427 





a <SA> represents the average RMS deviations for the ensemble of 35 structures. 
















Full-length Kd > 1 μM








































































[CIP4 HR1] (μM) [FBP17 HR1] (μM)[HR1SH3] (μM)
HR1SH3
 Kd = 4.66 ± 4 μM
CIP4 HR1
Kd = 5.05 ± 1.8 μM
FBP17 HR1
Kd = 10.5 ± 5.5 μM
EC D
ACK GBD Kd = 0.046 ± 0.006 μM
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